1-4 of 4
Authors: James M. Stafford
Sort by
Journal Article
PDCT-06. PHASE 1 STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH H3 K27M-MUTANT HIGH GRADE GLIOMA OR NEWLY DIAGNOSED DIPG Free
Sharon Gardner and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi201, https://doi.org/10.1093/neuonc/noy148.836
Published: 05 November 2018
Journal Article
DIPG-54. TREATMENT OF A PEDIATRIC PATIENT WITH AN H3.3 K27M MUTANT DIPG WITH ONC201, A SELECTIVE DRD2 ANTAGONIST Free
Fernando Suarez and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i60, https://doi.org/10.1093/neuonc/noy059.147
Published: 22 June 2018
Journal Article
EXTH-42. H3 K27M MUTANT GLIOMAS ARE SELECTIVELY KILLED BY ONC201, A SMALL MOLECULE INHIBITOR OF DOPAMINE RECEPTOR D2 Free
Andrew S Chi and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi81, https://doi.org/10.1093/neuonc/nox168.334
Published: 06 November 2017
Journal Article
Pediatric high-grade glioma: biologically and clinically in need of new thinking Open Access
Chris Jones and others
Neuro-Oncology, Volume 19, Issue 2, 1 February 2017, Pages 153–161, https://doi.org/10.1093/neuonc/now101
Published: 09 June 2016